This is a preview of subscription content, access via your institution
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Scientific Review of the Safety and Efficacy of Methods to Avoid Mitochondrial Disease through Assisted Conception (HFEA, 2011).
Scientific Review of the Safety and Efficacy of Methods to Avoid Mitochondrial Disease through Assisted Conception (HFEA, 2013).
Third Scientific Review of the Safety and Efficacy of Methods to Avoid Mitochondrial Disease through Assisted Conception : 2014 Update (HFEA, 2014).
Scientific Review of the Safety and Efficacy of Methods to Avoid Mitochondrial Disease through Assisted Conception : 2016 Update (HFEA, 2016).
Novel Techniques for the Prevention of Mitochondrial DNA Disorders: An Ethical Review (Nuffield Council on Bioethics, 2012).
The Human Fertilisation and Embryology (Mitochondrial Donation) Regulations No. 572 (HFEA, 2014).
United Kingdom, Parliament, House of Commons. Human fertilisation and embryology. Hansard, columns 160–187 (3 February 2015).
United Kingdom, Parliament, House of Lords. Human fertilisation and embryology (mitochondrial donation) regulations 2015. Hansard, columns 1569–1627 (24 February 2015).
Cellular, Tissue, and Gene Therapies Advisory Committee. Oocyte Modification in Assisted Reproduction for the Prevention of Transmission of Mitochondrial Disease or Treatment of Infertility Meeting No. 59 (FDA, 2014).
National Academies of Sciences, Engineering, and Medicine. Mitochondrial Replacement Techniques: Ethical, Social, and Policy Considerations (The National Academies Press, 2016).
Mitochondria Replacement Consultation: Advice to Government (HFEA, 2013).
Mitochondrial Donation: Government Response to the Consultation on Draft Regulations to Permit the Use of New Treatment Techniques to Prevent the Transmission of a Serious Mitochondrial Disease from Mother to Child (United Kingdom Department of Health, 2014).
HFEA permits cautious use of mitochondrial donation in treatment, following advice from scientific experts. HFEA https://www.hfea.gov.uk/about-us/news-and-press-releases/2016-news-and-press-releases/hfea-permits-cautious-use-of-mitochondrial-donation-in-treatment-following-advice-from-scientific-experts/ (2016).
HFEA statement on mitochondrial donation. HFEA https://www.hfea.gov.uk/about-us/news-and-press-releases/2017-news-and-press-releases/hfea-statement-on-mitochondrial-donation/ (2017).
Sherratt, S. Women selected for mitochondrial donation in UK. BioNews 936, 96351 (2018).
United States Public Law no. 115–141. Consolidated Appropriations Act 2018 (23 March 2018).
About this article
Cite this article
Adashi, E.Y., Caplan, A.L., Capron, A. et al. In support of mitochondrial replacement therapy. Nat Med 25, 870–871 (2019). https://doi.org/10.1038/s41591-019-0477-4
This article is cited by
Journal of Bioethical Inquiry (2023)
Easing US restrictions on mitochondrial replacement therapy would protect research interests but grease the slippery slope
Journal of Assisted Reproduction and Genetics (2019)